Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jun 19;2(25):447-452.
doi: 10.46234/ccdcw2020.088.

Sequencing the Complete Genome of COVID-19 Virus from Clinical Samples Using the Sanger Method

Affiliations

Sequencing the Complete Genome of COVID-19 Virus from Clinical Samples Using the Sanger Method

Roujian Lu et al. China CDC Wkly. .

Abstract

What is already known on this topic?

Coronavirus disease 2019 (COVID-19), a disease caused by a novel human coronavirus named the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or COVID-19 virus, was reported in December 2019. Complete genomes of the COVID-19 virus from clinical samples using next generation sequencing (NGS) have been reported.

What is added by this report?

Here we provide the technical data for sequencing complete genome of COVID-19 virus from clinical samples using the Sanger method. Two complete COVID-19 virus genome sequences (named WH19004-S and GX0002) were obtained from clinical samples of COVID-19 patients, and two single nucleotide polymorphisms (SNPs) in ORF7a (T/C, nt 27,493) and ORF8 (T/C, nt 28,253) of WH19004-S were identified by Sanger sequencing.

What are the implications for public health practice?

The COVID-19 virus genome sequencing by Sanger method reported here could be used to generate data of high enough quality without requirement for expensive NGS equipment, which support sequencing complete genomes from clinical samples and monitoring of viral genetic variations of COVID-19 infections.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: No conflicts of interest were reported.

Figures

Figure 1
Figure 1
COVID-19 virus genome fragment amplification by RT-PCR. A: Schematic representation of the amplificatory fragments of the genome. B: Capillary electrophoresis profiles of RT-PCR products of the obtained partial fragment. a to k: RT-PCR products of the fragment 1–11; l to m: RT-PCR products of the end of 5’ and 3’ of the genome.
Figure 2
Figure 2
Sequence comparison and Sanger sequencing diagram of COVID-19 virus in this study. (A) Sequence alignment of 4 whole-length genomes of COVID-19 virus. (B) Sanger sequencing diagram of WH19004-S by reverse primers 29R and 30R, which shows the SNPs in ORF7 and ORF8 of WH19004-S.

References

    1. Wang C, Horby PW, Hayden FG, Gao GF A novel coronavirus outbreak of global health concern. Lancet. 2020;3(10223):470–3. doi: 10.1016/S0140-6736(20)30185-9. - DOI - PMC - PubMed
    1. Tan WJ, Zhao X, Ma XJ, Wang WL, Niu PH, XU WB, et al. Notes from the field: a novel coronavirus genome identified in a cluster of pneumonia cases-Wuhan, China 2019−2020. China CDC Weekly 2020; 2(4): 61-2. http://weekly.chinacdc.cn/en/article/id/a3907201-f64f-4154-a19e-4253b453d10c.

    1. Zhu N, Zhang DY, Wang WL, Li XW, Yang B, Song JD, et al A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;3(8):727–33. doi: 10.1056/NEJMoa2001017. - DOI - PMC - PubMed
    1. Huang CL, Wang YM, Li XW, Ren LL, Zhao JP, Hu Y, et al Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;3(10223):15–21. doi: 10.1016/s0140-6736(20)30183-5. - DOI - PMC - PubMed
    1. Coronaviridae Study Group of the International Committee on Taxonomy of Viruses The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2 . Nat Microbiol. 2020;3(4):536–44. doi: 10.1038/s41564-020-0695-z. - DOI - PMC - PubMed

LinkOut - more resources